Depreciation of Vanda Pharmaceuticals Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vanda Pharmaceuticals Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Vanda Pharmaceuticals Inc. Depreciation for the quarter ending 31 Mar 2025 was $231,000, a 12% increase year-over-year.
  • Vanda Pharmaceuticals Inc. annual Depreciation for 2025 was $1,103,000, a 28% increase from 2024.
  • Vanda Pharmaceuticals Inc. annual Depreciation for 2024 was $859,000, a 6.6% decline from 2023.
  • Vanda Pharmaceuticals Inc. annual Depreciation for 2023 was $920,000, a 24% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Vanda Pharmaceuticals Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,103,000 +$244,000 +28% 01 Jan 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
2024 $859,000 -$61,000 -6.6% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
2023 $920,000 -$297,000 -24% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
2022 $1,217,000 -$146,000 -11% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $1,363,000 -$23,000 -1.7% 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2024 2023 FY
2020 $1,386,000 -$1,000 -0.07% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
2019 $1,387,000 -$42,000 -2.9% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $1,429,000 +$195,000 +16% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021 2020 FY
2017 $1,234,000 +$299,000 +32% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $935,000 +$353,000 +61% 01 Jan 2016 31 Dec 2016 10-K 19 Feb 2019 2018 FY
2015 $582,000 +$52,000 +9.8% 01 Jan 2015 31 Dec 2015 10-K 15 Feb 2018 2017 FY
2014 $530,000 +$98,000 +23% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $432,000 01 Jan 2013 31 Dec 2013 10-K 12 Feb 2016 2015 FY

Vanda Pharmaceuticals Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $231,000 +$25,000 +12% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $206,000 -$85,000 -29% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $291,000 -$32,000 -9.9% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $323,000 -$22,000 -6.4% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $345,000 -$6,000 -1.7% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $351,000 +$19,000 +5.7% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $332,000 -$17,000 -4.9% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $349,000 +$99,000 +40% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q1 2017 $250,000 +$31,000 +14% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $219,000 +$79,000 +56% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $140,000 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.